Development of Adherence Biomarkers for Multiple Microbicide and Multipurpose Prevention Technology (MPT) Dosage Forms
Completed · Phase 1 · Has a placebo group
Conditions studied: HIV
In brief
The purpose of this study is to develop markers for use of placebo vaginal products and measure markers of mucosal semen exposure among healthy women. The study will also monitor safety of placebo product use.
Key facts
- Study ID
- NCT02569697
- Run by
- CONRAD
- People needed
- 50
- Starts
- 2015-10-01
- Expected to finish
- 2016-05-01
- Last updated by the study team
- 2016-09-02
Who can join
Age: 18 and older, up to 50. Sex: female. Healthy volunteers: accepted.
Where it is running
- Eastern Virginia Medical School — Norfolk, Virginia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.